Benjamin Moon MD

MD/Ph.D Student. Ph.D, Immunology

6201 Harry Hines BlvdDallas, TX 75390

Dr. Moon is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moon's full profile Already have an account?

Education & Training

University of Texas Southwestern Medical SchoolClass of 2024
Brown UniversityBS, Biochemistry, 2010 - 2014

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Awards, Honors, & Recognition

NRSA F30 Fellowship NCI, NIH, 2021-2023

Publications & Presentations

PubMed

81 citations
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors.
Diyuan Xue, Benjamin Moon, Jing Liao, Jingya Guo, Zhuangzhi Zou
Science Immunology. 2022-01-07
93 citations
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.
Eric Hsu, Xuezhi Cao, Benjamin Moon, Joonbeom Bae, Zhichen Sun
Nature Communications. 2021-05-13
52 citations
RTP4 Is a Potent IFN-Inducible Anti-flavivirus Effector Engaged in a Host-Virus Arms Race in Bats and Other Mammals.
Ian N. Boys, Elaine Xu, Katrina B. Mar, Pamela C. De La Cruz-Rivera, Jennifer L. Eitson
Cell Host & Microbe. 2020-11-11